Hyperlipoproteinemic states and ischemic heart disease.
Ischemic heart disease and contributing risk factors such as the hyperlipoproteinemic states affect a great percentage of the general population. Because these disease processes can effectively place patients at risk for a life-threatening event, every health care provider must be knowledgeable, disciplined to take a thorough medical history, and prepared for emergency situations that may arise in the clinical practice of dentistry. A proactive approach to identification of risk factors and to primary prevention of ischemic heart disease not only helps to lengthen and improve the quality of patient's lives, but also ensures that necessary modifications of treatment reflect each patient's medical and pharmacologic status.
Prusinski
L
L
Oral Medicine Department, Naval Dental School, National Naval Dental Center, Bethesda, Maryland, USA.
Eisold
J F
JF
D002317:Cardiovascular Agents / Q000627:therapeutic use; D017742:Dental Care for Chronically Ill; D004630:Emergencies; D006801:Humans; D006951:Hyperlipoproteinemias / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008487:Medical History Taking; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D011788:Quality of Life; D012307:Risk Factors
D002317:Cardiovascular Agents; D000960:Hypolipidemic Agents